This Is Where The Amazing Was Started

PT Eisai Indonesia's career began in 1968, starting with Eisai Co., Ltd which started marketing operations in Indonesia. Eisai started its business by focusing on the health of patients and their families. Continues to grow and expand in Indonesia until now PT Eisai Indonesia has been contributing to the health of the Indonesian people for more than 50 years.

PTEI JOURNEY

1968

1970

1976

1986

1987

1968

Eisai Co, Ltd started marketing operations in Indonesia

1970

PT Eisai Indonesia (PTEI) established and approved by the President of the Republic of Indonesia

1976

Kebun Pertjobaan Tjianjur was inaugurated by the Indonesian Minister of Health.

1986

KPT published 1st Edition Book of Medicinal Herbs Index

1987

Message from CEO Yuji Naito (2nd generation of Naito`s family) written Think Positive. CEO Naito sharing that Eisai member have to think positive during their activity.

PTEI Factory moved to Citeureup, Bogor, and was inaugurated by the Ministry of Health of the Republic of Indonesia.

PTEI JOURNEY

1989

1990

1994

1999

2000

1989

Exported medicine to Japan for the first time

1990

Expanded the export of medicine to Thailand.

1994

Obtained GMP Certificates and Certificate of Analyses of Environmental Impacts.

1999

Innovation Medicine for treatment to Alzheimer's Disease, launched as Eisai Global Product

2000

Novel Medicine for treatment to Gastroentherology, launched as Eisai Global Product

PTEI JOURNEY

2010

2011

2015

2017

2020

2010

Bogor Factory was awarded “Zero Accident Award” by Ministry of Manpower and Transmigration of Republic of Indonesia.

2011

 

For the second time, Bogor Factory was awarded “Zero Accident Award” by Ministry of Manpower and Transmigration of Republic of Indonesia. Bogor Factory was awarded “Environment Conservation Award” by Bogor government.

2015

1st Eisai Global Oncology product for Metastatic Breast Cncer (MBC) was launched

2017

2nd Eisai Global Oncology Product for Differentiated Thyroid Cancer (DTC) launched as Eisai Global Product

2020

New indication for 2nd Eisai Global Oncology product as Hepato Cellular Carcinoma (HCC) launched

PTEI JOURNEY

2021

2022

2023

2021

The latest Halal Certification for PTEI factory was approved by Indonesia's Ministry of religion 

2022

1st  Eisai global product on Dual Orexin Receptor Antagonist (DORA) indicated
for the treatment of insomnia was launched

2023

The worlds 1st IBAT Inhibitor which uses the Dual Action of Bile Acids as Physiological Laxative for Chronic Constipation